On learning last year she was pregnant with her second child, Cailyn Morreale was overcome with fear and trepidation.
Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023 – Biotech Investments
Medacta Group SA / Key word(s): Annual Results/Annual Results 13-March-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The
March 14, 2024